Case Report
Anticoagulant Related Nephropathy Induced by Dabigatran
| | Test | Result | Ref. Range | Abnormality |
| | Serum Sodium | 137 mmol/L | 133 – 145 mmol/L | | | Serum Potassium | 4.5 mmol/L | 3.3 – 5.1 mmol/L | | | Serum Chloride | 104 mmol/L | 98 – 111 mmol/L | | | Serum Bicarbonate | 19 mmol/L | 21 – 31 mmol/L | | | Serum Creatinine | 177 umol/L | 35 – 100 umol/L | Abnormal | | Hemoglobin | 118 g/L | 123 – 157 g/L | | | White Blood Count | 16.8 X 109/L | 4 – 10 X 109/L | Abnormal | | Platelet | 217 X 109/L | 130 – 400 X 109/L | | | INR | 1.6 | ≤ 1.1 | Abnormal | | aPTT | 50 seconds | 28 – 38 seconds | Abnormal | | Antinuclear Antibodies, Anti DS- DNA antibodies, | Negative | | | | C-ANCA, P-ANCA | Negative | | | | Anti-Glomerular Basement Membrane Antibody | Negative | | | | C3, C4 | Normal | | | | HIV, Hepatitis serology | Negative | | | | Serum IgA | 5.85 g/L | 0.60 – 4.20 g/L | Abnormal | | Anti-Streptolysin O titer | 449 IU/mL | 0-200 IU/mL | Abnormal | | Free Kappa | 223 mg/L | 3.3 – 19.4 mg/L | Abnormal | | Free Lambda | 70.50 mg/L | 5.71 – 26.3 mg/L | Abnormal | | Kappa: Lambda Ratio | 3.16 | 0.26 – 1.65 | Abnormal |
|
|
